A literature lover who likes delving deeper into a wide range of societal issues and expresses her opinions about the same. Keeps looking for best-read recommendations while enjoying her coffee and tea.
In a recent study, Dr Thayumanavan and his research team investigated the use of a thyromimetic drug, which mimics synthetic thyroid hormone, as a potential solution for weight loss and cholesterol reduction.
In a recent study, Dr Thayumanavan and his research team investigated the use of a thyromimetic drug, which mimics synthetic thyroid hormone, as a potential solution for weight loss and cholesterol reduction. The drug's unique mechanism of action involves targeting the thyroid hormone receptor beta, predominantly found in the liver, to activate various physiological responses, including fatty acid oxidation and the reverse cholesterol pathway. These findings offer exciting prospects for addressing obesity and high cholesterol levels, although further research is needed to confirm these promising results.
All section
